USA, multiple locations - 10 Sep `20Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

 

Official Title: Multi-Arm Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

In Brief: This is a prospective study to evaluate the application of Spray-On Skin™ Cells, prepared using the RECELL® Device for safe and effective repigmentation of ablated stable vitiligo lesions.

Ages Eligible: 18 Years and older 

Start Date: September 10, 2020

Completion Date (estimated): March 2023

Status: Recruiting

Study ID from ClinicalTrials.gov: NCT04547998
Other Study ID Numbers: CTP009

Locations:

  • Irvine, CA
  • Greenwood Village, CO
  • Miami, FL
  • Worcester, MA
  • Detroit, MI

Contact: To learn more about this study, you or your doctor may contact 

Elizabeth Kirshner
6613676869
ekirshner@avitamedical.com
 
Lisa Carothers
6614814663
lcarothers@avitamedical.com

Please refer to this study by its NCT number.

FAQOther Questions

  • Who is prone to vitiligo?

    Scientists know that some people are genetically predisposed to a specific group of autoimmune diseases – including generalized vitiligo – but do not know who and why.It doesn’t...

  • Pyrostegia venusta as a folk medicine for vitiligo?

    Pyrostegia venusta is a neotropical evergreen vine widely spread in Brazil throughout fields, at the coast, edge of the woods and along roadsides (see photo below). Popularly kn...

  • Does halo nevi affect vitiligo development?

    Halo nevi — nevi with an depigmented circle around it, usually on the trunk — are about 10x more common in vitiligo patients than in the general population, especially in childr...